Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Melaleuca alternifolia, commonly known as tea tree oil, has a long history of traditional use among Indigenous Australians for treating wounds and skin infections. In recent decades, scientific research has investigated its antimicrobial properties, particularly against Staphylococcus aureus, including methicillin-resistant strains (MRSA). In vitro studies have demonstrated that tea tree oil exhibits significant bactericidal activity against Staph species, disrupting bacterial cell membranes and inhibiting growth. Some clinical trials and case reports suggest topical tea tree oil (at concentrations of 5%–10%) may reduce colonization or infection, especially for mild superficial infections such as impetigo or minor wounds. However, evidence from large, well-designed randomized controlled trials is limited, and results are mixed, with some studies indicating modest benefit and others showing no significant difference compared to standard treatments.

Safety concerns include potential skin irritation or allergic reactions, and tea tree oil should not be ingested. While laboratory evidence supports its antibacterial effects, and small-scale clinical data are encouraging, tea tree oil is not a substitute for standard systemic antibiotic therapy in serious or deep Staph infections. It may be considered as an adjunct or alternative for minor topical infections where antibiotic resistance or intolerance is a concern. Thus, the use of Melaleuca alternifolia for supporting the treatment of Staph infections is scientifically plausible but supported by only moderate clinical evidence.

More about melaleuca alternifolia
More about Staph Infections

Other ingredients used for Staph Infections

Other health conditions supported by melaleuca alternifolia

Products containing melaleuca alternifolia